title: Targeted expression of a multifunctional chimeric neurotrophin in the lesioned sciatic nerve accelerates regeneration of sensory and motor axons.
abstract: Peripheral nerve injury markedly regulates expression of neurotrophins and their receptors in the lesioned nerve. However, the role of endogenously produced neurotrophins in the process of nerve regeneration is unclear. Expression of a multifunctional neurotrophin, pan-neurotrophin-1 (PNT-1), was targeted to the peripheral nerves of transgenic mice by using a gene promoter that is specifically activated after nerve lesion but that is otherwise silent in all other tissues and during development. PNT-1 is a chimeric neurotrophin that combines the active sites of the neurotrophins nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 and binds and activates all known neurotrophin receptors. In adult transgenic mice, PNT-1 was highly expressed in transected but not in intact sciatic nerve. Morphometric analyses at the electron microscopy level showed increased and accelerated recovery of axon diameter of myelinated fibers in crushed peripheral nerves of transgenic mice compared with wild type. Examination of nerve bundles in target tissues indicated accelerated reinnervation of foot pad dermis and flexor plantaris muscle in transgenic mice. Moreover, transected sensory and motor axons of transgenic mice showed faster and increased return of neurophysiological responses, suggesting an accelerated rate of axonal elongation. Importantly, transgenic mice also showed a markedly ameliorated loss of skeletal muscle weight, indicating functional regeneration of motor axons. Together, these data provide evidence, at both the anatomical and functional levels, that neurotrophins endogenously produced by the lesioned nerve are capable of significantly accelerating the regeneration of both sensory and motor axons after peripheral nerve damage. In addition, our results indicate that exogenous PNT-1 administration may be an effective therapeutic treatment of peripheral nerve injuries.
authors.affiliation: Department of Neuroscience, Karolinska Institute, 171 77 Stockholm, Sweden.
authors.forename: H
authors.initials: H
authors.lastname: Funakoshi
authors.forename: M
authors.initials: M
authors.lastname: Risling
authors.forename: T
authors.initials: T
authors.lastname: Carlstedt
authors.forename: U
authors.initials: U
authors.lastname: Lendahl
authors.forename: T
authors.initials: T
authors.lastname: Timmusk
authors.forename: M
authors.initials: M
authors.lastname: Metsis
authors.forename: Y
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: C F
authors.initials: CF
authors.lastname: Ibáñez
mesh_terms: D000818:Animals; D001369:Axons / Q000502:physiology; D051379:Mice; D008822:Mice, Transgenic; D009046:Motor Neurons / Q000166:cytology*; D018482:Muscle, Skeletal / Q000033:anatomy & histology; D009132:Muscles / Q000294:innervation; D009409:Nerve Crush; D009414:Nerve Growth Factors / Q000008:administration & dosage* / Q000235:genetics; D009416:Nerve Regeneration; D009475:Neurons, Afferent / Q000166:cytology*; D009929:Organ Size; D011993:Recombinant Fusion Proteins; D012584:Sciatic Nerve; D012867:Skin / Q000294:innervation
chemical_list: D009414:Nerve Growth Factors; D011993:Recombinant Fusion Proteins